Moderna (Nasdaq: MRNA) has received a potential $1.74 billion contract to initially produce and deliver 66 million doses of its
Moderna (Nasdaq: MRNA) has secured a $3.3 billion contract modification from the U.S. Army for additional 200 million filled drug
The departments of Health and Human Services and Defense have earmarked $3.65 billion to buy 100 million additional doses of…
Moderna has received a six-month, $1.97B contract modification from the U.S. Army to manufacture 100M more doses of the company's…
The departments of Health and Human Services and Defense have signed a potential $1.5B agreement with Moderna to produce 100M…
Moderna has been awarded a potential $472M contract modification by the Biomedical Advanced Research and Development Authority to expand late-stage clinical trials of the…
The Biomedical Advanced Research and Development Authority has awarded Moderna a potential $483M contract to further develop a vaccine against to…
